Lupin Builds Momentum As It Anticipates FDA Action On Spiriva Rival

Recent Boosts Also Include EIR For Nagpur Plant As Well As US Lurasidone Launch

 
• By Dave Wallace
  
Newton's Cradle with red ball
Action on Lupin’s Spiriva generic is expected to add to US momentum • Source: Shutterstock

More from Earnings

More from Business